We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Brentuximab extravasation injury in a patient with mycosis fungoides with large cell transformation.
- Authors
Kim, Eileen; Walker, Amanda; Bhate, Chinmoy; Chang, Victor T.
- Abstract
The diagnosis of BV extravasation injury was made and the patient was treated with local emollients. Primary cutaneous lymphomas are non-Hodgkin lymphomas without extracutaneous disease at the time of diagnosis and are typically indolent.1,2 CD30 positivity may suggest the potential for large cell transformation and progression.3 Brentuximab vedotin (BV) is an anti-CD30 antibody-drug conjugate newly approved to treat CD30+ cutaneous lymphomas.1 An 87-year-old man was diagnosed with patch-stage mycosis fungoides.
- Subjects
MYCOSIS fungoides; EXTRAVASATION; CELL transformation; WOUNDS &; injuries; CUTANEOUS T-cell lymphoma
- Publication
Dermatologic Therapy, 2022, Vol 35, Issue 10, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.15751